Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced today that it has signed definitive agreements to sell its Athena Diagnostics and Lancaster Laboratories ...
Quest will pay $740 million for neurology testing firm Athena, while Eurofins gains contract testing capabilities. Thermo Fisher Scientific is to sell its Athena Diagnostics business to Quest ...
WALTHAM, Mass.-- (BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced today that it has signed definitive agreements to sell its Athena ...
BOSTON, July 29, 2025 /PRNewswire/ -- Athena Diagnostics, the specialty neurology business of Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced a ...
Athena Diagnostics, a leader in neurological diagnostics, today announced the clinical availability of new genetic tests to aid the detection of several rare neurological disorders, including ...
I was at the JP Morgan Healthcare Conference when I learned a week ago that the Supreme Court of the United States (SCOTUS) had denied Athena Diagnostic’s Petition for Certiorari. I was shocked. We ...
New test utilizes technology based on PacBio's (PACB) PureTarget sequencing method to uncover genetic causes of disease BOSTON, July 29, 2025 /PRNewswire/ -- Athena Diagnostics, the specialty ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results